Oasis Fertility, Hyderabad based specialty healthcare startup, has raised $50 million from Kedaara Capital to amplify its efforts to make strategic headways in the current market.
In a statement the company stated that a significant minority stake worth $50 million was bought by Kedaara Capital. There was also a commitment to deploy further capital for strategic acquisitions and support Oasis in becoming the leading fertility chain in India and adjacent markets. The transaction will provide an exit to InvAscent, who invested in the company in 2016.
Founded by DrDurga G. Rao and KiranGadela in 2009, Oasis Fertilityhas scaled to a network of 26 clinics across 16 cities. The startup has doubled its revenues in the last three years. Oasis recently launched first-of-its-kind andrology (male infertility) practice called AndroLife.
Speaking about the investment, Nishant Sharma, CIO & Managing Partner of Kedaara Capital said, “Oasis has created a scalable, replicable model and espouses a unique culture with clinical excellence and ethics at its core”.
The freshly raused funds will be utilized to expand the company's brand presence across India. The healthcare startup will also hire more support staff to manage the increase in demand for speciality healthcare-based services.
KiranGadela, Co-founder and Managing Director, Oasis Fertility said, “We are delighted about leveraging Kedaara’s understanding of the sector and the Indian market. We look forward to this partnership as we embark on a journey to pursue attractive synergistic acquisitions and create a leading fertility platform in India and South Asia to further our core purpose of helping couples achieve parenthood.”
